Regenerative Biotechnology
Gencell® CTM Metformin
Mesenchymal stem cells pretreated with metformin for metabolic and regenerative support.
Injectable solution of mesenchymal stem cells pretreated with metformin, designed to modulate inflammation, improve glycemic regulation, and support tissue regeneration in metabolic and musculoskeletal conditions.
Composition
Mesenchymal stem cells pretreated with metformin.
Pharmaceutical form
Injectable solution.
Presentation
Single-dose vial, 4 ml.
Therapeutic properties
Promote tissue repair through immunomodulation, apoptosis inhibition, cellular stimulation, promotion of angiogenesis, and improved glucose uptake by reducing insulin resistance.
- Modulation of tissue inflammation.
- Improvement of glucose uptake.
- Reduction of insulin resistance.
- Inhibition of cellular apoptosis.
- Stimulation of tissue regeneration.
- Promotion of angiogenesis.
- Support for glycemic regulation.
- Supports bone and cartilage regeneration.
Mechanism of action & Clinical data
Migrate to damaged tissues, modulate inflammation, inhibit apoptosis and, via OCT-1, increase GLUT2 and GLUT4 expression, improving glycemic homeostasis and tissue regeneration.